An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants
Clinical trial NCT03563950 · COMPLETED
Trial details
- NCT number
- NCT03563950
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2018-07-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.